Source: Eur Respir Mon; 2003: 26: 105–129



Rating:

Share or cite this content

Citations should be made in the following way:
C. Knoop, A. Haverich, S. Fischer. Immunosuppressive therapy after human lung transplantation. Eur Respir Mon; 2003: 26: 105–129

Member's Comments

No comment yet.

Related content which might interest you: Immunosuppressive therapy after human lung transplantation Source: Eur Respir J 2004; 23: 159-171 Year: 2004 Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001 Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Medical complications of lung transplantation Source: Eur Respir J 2004; 23: 334-342 Year: 2004 A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010 How to use new immunosuppressive drugs in lung transplantation Source: Annual Congress 2006 - MP5 – How to use new immunosuppressive drugs in lung transplantation Year: 2006 The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Impact of antifibrotic drugs in lung transplantation Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003 Early sirolimus immunosuppression is safe in lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Lymphoma's and rejection after lung transplantation: balancing the immunosuppression Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression Year: 2005 Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab? Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Airway cellular response to two different immunosuppressive regimens in lung transplant recipients Source: Eur Respir J 2004; 24: Suppl. 48, 466s Year: 2004 Side-effects of antituberculosis drug treatment in patients with chronic renal failure Source: Eur Respir J 2002; 20: 440-443 Year: 2002 Azathioprine discontinuation and medium and long term outcomes after lung transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Effects of two immunosuppressive triple therapies on inflammatory cells in lung Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017 Year: 2017